Intravenous iron supplementation in heart failure patients induces temporary endothelial dysfunction with release of endothelial microvesicles

BACKGROUND: Intravenous iron supplementation is an established therapy for patients with heart failure (HF) and concomitant iron deficiency reducing the risk of HF hospitalization. However, concerns persist regarding potential adverse vascular effects, since iron may induce oxidative stress, inflamm...

Descripción completa

Detalles Bibliográficos
Autores principales: Mause, Sebastian F., Berger, Martin, Lim, Hwee Ying, Vogt, Felix, Brandenburg, Vincent, Stöhr, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904167/
https://www.ncbi.nlm.nih.gov/pubmed/36761158
http://dx.doi.org/10.3389/fimmu.2022.1092704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904167/
https://www.ncbi.nlm.nih.gov/pubmed/36761158
http://dx.doi.org/10.3389/fimmu.2022.1092704

Ejemplares similares